China SXT Pharmaceuticals Inc
NASDAQ:SXTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CSG Holding Co Ltd
SZSE:000012
|
CN |
|
N
|
Nuenergy Holdings Bhd
KLSE:NHB
|
MY |
|
M
|
Macquarie Mexico Real Estate Management SA de CV
BMV:FIBRAMQ12
|
MX |
China SXT Pharmaceuticals Inc
Operating Expenses
China SXT Pharmaceuticals Inc
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
|
Operating Expenses
-$8.7m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Expenses
-¥7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Expenses
-¥18.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-13%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Expenses
-¥7.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Operating Expenses
-¥2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-12%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Operating Expenses
-¥1.8B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
China SXT Pharmaceuticals Inc
Glance View
China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 96 full-time employees. The company went IPO on 2019-01-04. The firm develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The firm sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.
See Also
What is China SXT Pharmaceuticals Inc's Operating Expenses?
Operating Expenses
-8.7m
USD
Based on the financial report for Sep 30, 2025, China SXT Pharmaceuticals Inc's Operating Expenses amounts to -8.7m USD.
What is China SXT Pharmaceuticals Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
1%
The average annual Operating Expenses growth rates for China SXT Pharmaceuticals Inc have been -25% over the past three years , 1% over the past five years .
